コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 in the anophthalmic group (P = .003), while urological abnormalities were particularly seen in the O
2 ancy-related factors, gynecological factors, urological and gastrointestinal tract factors, comorbid
6 rehensive Cancer Network (NCCN) and American Urological Association (AUA) provide guidelines for surv
7 tract symptom questionnaire of the American Urological Association (n = 1934); non-cases were men wh
8 he European Association of Urology, American Urological Association and National Institute of Clinica
9 he 2003 and 2004 proceedings of the American Urological Association as well as published literature f
10 The guidelines presented by the American Urological Association give a formal framework for the m
11 we suggest modifications to the new American Urological Association guidelines based on the authors'
12 Francisco Matching Program, and the American Urological Association Matching Program from 1996 to 200
13 ancer Prevention Committee, and the American Urological Association Practice Guidelines Committee joi
15 Patients were grouped by age per American Urological Association screening guidelines: group 1, pa
17 s were changes in the scores on the American Urological Association Symptom Index (AUASI) and the max
18 ry flow rate of at least 4 mL/s, an American Urological Association Symptom Index (AUASI) score of be
19 ymptom severity was assessed by the American Urological Association Symptom Index (AUASI), and peak u
21 symptom questions modified from the American Urological Association symptom index in 1992 and 1994 (n
22 te and who scored 0-7 points on the American Urological Association symptom index on all questionnair
23 f moderate/severe urinary symptoms (American Urological Association Symptom Index score >7), low maxi
26 r progression of BPH as measured by American Urological Association Symptom Index scores, peak urinar
27 evere LUTS (> or = 15 points on the American Urological Association symptom index) on any study quest
28 se line of at least 4 points in the American Urological Association symptom score, acute urinary rete
30 rved clinical examination data, the American Urological Association Symptoms Score showed a surprisin
31 Medicine, American Cancer Society, American Urological Association, and U.S. Preventive Services Tas
35 ll carcinoma (RCC), the third most prevalent urological cancer, claims more than 100,000 lives/year w
37 implications between tissue-oriented domains.Urological cancers have disparate tissues and cells of o
38 nsive molecular characterization to classify urological cancers into nine major genomic subtypes, hig
40 recent years, although it is plain that the urological community is still divided regarding their us
43 evere irritative symptoms or the presence of urological comorbidity, such as bladder stones, increase
45 led for the potential confounders sex, age, (urological) comorbidity, febrile UTI, and intensive care
48 ent placement in children in this era of low urological complication rates and BKVAN needs reevaluati
49 sed, but associated with a high incidence of urological complications (acidosis, dehydration, pancrea
51 .39-0.80; p = 0.001) for the total number of urological complications 0.56 (CI 0.41-0.76; p < 0.001)
55 ons, including events such as lymphocele and urological complications that affect wound healing, are
56 ncidence of posttransplantation vascular and urological complications, long-term graft survival after
58 nting in renal transplantation reduces major urological complications; however, morbidity is related
59 infrequently seen and challenging pediatric urological condition that in addition to causing obstruc
61 tions in DSTYK were implicated in congenital urological developmental disorders, but our study identi
63 -jet flows, and apply this to the problem of urological diagnosis in this first ever study of the bio
64 d forms of CA, are less common but can cause urological disease including urinary retention and prost
66 ma in a large group of patients with various urological disorders could be used in the diagnosis of o
71 ee groups (1:1:1; stratified by tumour site [urological, gynaecological, or gastrointestinal], and de
72 we recommend that only patients with a prior urological history should undergo this costly and often
73 VCUG studies to those patients with a prior urological history would have resulted in a significant
75 ast 10 years, we have seen major advances in urological imaging including developments in digital ima
77 herapeutic gain, are well exemplified by the urological malignancies of renal, bladder, prostate, and
83 ymptoms or complications need referral for a urological opinion to determine the need for further inv
85 ews the different approaches used by leading urological organizations to the development of prostate
87 by tumor cells were blindly evaluated by two urological pathologists, and outcome analyses were condu
91 nificantly enhanced at later stages when the urological phenotype is severe, and the mutant bladders
92 g the potential application of proteomics in urological practice, and the future direction of proteom
93 trials cannot always be generalized to daily urological practice, it is important to complement them
100 The samples associated with drug toxicity, urological problems, or recurrence of primary disease we
101 pen surgery for commonly performed pediatric urological procedures such as pyeloplasty, ureteral reim
102 iotic treatment only for patients undergoing urological procedures that lead to mucosal bleeding, cat
103 tial number of reports on performing complex urological procedures with robotic assistance in humans
108 e sites (Carcinoma of the Prostate Strategic Urological Research Endeavor, Center for Prostate Diseas
115 pread in the diagnostic evaluation of common urological symptoms, the planning of surgery and the tra
117 omography scanning is capable of visualizing urological tumours and associated lymph nodes and distal
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。